Company: ANTX
Filing Date: 2025-06-11
Form Type: 8-K
Source: 0001193125-25-138796
Chunk: 0

Company: AN2 Therapeutics, Inc.
Filing Date: 2025-06-11
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01.      Regulation FD Disclosure.  

On June 11, 2025, AN2 Therapeutics, Inc. (the “ Company”) posted an updated investor presentation on the “ Investors” section of its website, which is furnished as Exhibit 99.1 hereto and is incorporated by reference herein.

The information in this Item 7.01, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U. S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.